Thomas Jennings
Chief Operating Officer at Morphick, Inc.
Profile
Thomas P.
Jennings is currently the Director at Ausio Pharmaceuticals LLC and the COO, Corporate Secretary & General Counsel at Morphick, Inc. He previously served as the President at PediaMed Pharmaceuticals, Inc. from 2002 to 2007 and as the Secretary & General Counsel at Xanodyne Pharmaceuticals, Inc. He was also the President at Union Springs LLC from 1999 to 2007.
Jennings holds a graduate degree from Northern Kentucky University and an undergraduate degree from the University of Cincinnati (Ohio).
Thomas Jennings active positions
Companies | Position | Start |
---|---|---|
Ausio Pharmaceuticals LLC
Ausio Pharmaceuticals LLC BiotechnologyHealth Technology Ausio Pharmaceuticals LLC develops pharmaceutical products for the aging population. It offers AUS-131, a nonsteroidal, nonhormonal estrogen receptor ß (ERß) agonist that offers a potentially safer alternative to estrogen for the treatment of menopausal symptoms. The company was founded in 2006 and is headquartered in Cincinnati, OH. | Director/Board Member | - |
Morphick, Inc.
Morphick, Inc. Packaged SoftwareTechnology Services Morphick, Inc. provides cyber security managed detection and response services. It offers professional services such as incident response, compromise assessment, threat hunting and malware and security defense assessment. The company was founded by Paul Fry, Michael Picton, Brian Klenke and Brian Minick in 2015 and is headquartered in Cincinnati, OH. | Chief Operating Officer | - |
Former positions of Thomas Jennings
Companies | Position | End |
---|---|---|
PediaMed Pharmaceuticals, Inc.
PediaMed Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology PediaMed Pharmaceuticals, Inc. develops and markets pharmaceutical products. The company provides medicine in therapeutic categories, including respiratory and allergy, infectious disease, gastroenterology, and central nervous systems. The company was founded in 1999 and is headquartered in Florence, KY. | President | 28/02/2007 |
Union Springs LLC
Union Springs LLC Investment ManagersFinance Union Springs LLC (Union Springs) is a venture capital firm founded in 1998 by Roger D. Griggs. The firm is headquartered in Fort Mitchell, Kentucky. | President | 28/02/2007 |
Xanodyne Pharmaceuticals, Inc.
Xanodyne Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Xanodyne Pharmaceuticals, Inc. operates as an integrated specialty pharmaceutical company with both development and commercial capabilities focused on pain management and women's healthcare. It markets a portfolio of prescription pharmaceuticals and a line of prenatal vitamins. The firm's product candidates include XP12B, a tranexamic acid modified release oral tablet for the reduction of menstrual blood loss in women, who suffer from menorrhagia or excessive menstrual bleeding; and XP20B is a combination propoxyphene and acetaminophen modified release oral tablet for the treatment of mild to moderate pain. The company was founded by Gilbert R. Gonzales and Roger Dale Griggs in May 2001 and is headquartered in Newport, KY. | General Counsel | - |
Training of Thomas Jennings
Northern Kentucky University | Graduate Degree |
University of Cincinnati (Ohio) | Undergraduate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
Private companies | 5 |
---|---|
PediaMed Pharmaceuticals, Inc.
PediaMed Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology PediaMed Pharmaceuticals, Inc. develops and markets pharmaceutical products. The company provides medicine in therapeutic categories, including respiratory and allergy, infectious disease, gastroenterology, and central nervous systems. The company was founded in 1999 and is headquartered in Florence, KY. | Health Technology |
Xanodyne Pharmaceuticals, Inc.
Xanodyne Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Xanodyne Pharmaceuticals, Inc. operates as an integrated specialty pharmaceutical company with both development and commercial capabilities focused on pain management and women's healthcare. It markets a portfolio of prescription pharmaceuticals and a line of prenatal vitamins. The firm's product candidates include XP12B, a tranexamic acid modified release oral tablet for the reduction of menstrual blood loss in women, who suffer from menorrhagia or excessive menstrual bleeding; and XP20B is a combination propoxyphene and acetaminophen modified release oral tablet for the treatment of mild to moderate pain. The company was founded by Gilbert R. Gonzales and Roger Dale Griggs in May 2001 and is headquartered in Newport, KY. | Health Technology |
Union Springs LLC
Union Springs LLC Investment ManagersFinance Union Springs LLC (Union Springs) is a venture capital firm founded in 1998 by Roger D. Griggs. The firm is headquartered in Fort Mitchell, Kentucky. | Finance |
Ausio Pharmaceuticals LLC
Ausio Pharmaceuticals LLC BiotechnologyHealth Technology Ausio Pharmaceuticals LLC develops pharmaceutical products for the aging population. It offers AUS-131, a nonsteroidal, nonhormonal estrogen receptor ß (ERß) agonist that offers a potentially safer alternative to estrogen for the treatment of menopausal symptoms. The company was founded in 2006 and is headquartered in Cincinnati, OH. | Health Technology |
Morphick, Inc.
Morphick, Inc. Packaged SoftwareTechnology Services Morphick, Inc. provides cyber security managed detection and response services. It offers professional services such as incident response, compromise assessment, threat hunting and malware and security defense assessment. The company was founded by Paul Fry, Michael Picton, Brian Klenke and Brian Minick in 2015 and is headquartered in Cincinnati, OH. | Technology Services |
- Stock Market
- Insiders
- Thomas Jennings